Focal Epilepsy

Drug under Investigation:  Lamictal (Lamotrigine) extended release

Purpose of Study:  To assess the efficacy of once daily adjunctive therapy with LTG extended-release in subjects with partial seizures.

Inclusion Criteria:

• Is 13 years old or older
• Diagnosis of epilepsy with partial seizures for more than 24 weeks prior to study
• Has a documented history of partial seizures
• Has at least 8 partial seizures during an 8-week prospective Baseline Phase
• Is currently treated with a stable regimen of one or two AED(s) for at least four weeks prior to study

Exclusion Criteria:

• Is currently using or has previously used lamotrigine or felbamate
• Exhibits any primary generalized seizures
• Is taking three or more background AEDs chronically
• History of status epilepticus within the 24 weeks prior to study
• Is abusing alcohol and/or other substance(s)

If you qualify, all study related care is provided at no charge including:

• Study visits and study related procedures/tests
• Laboratory tests
• Study medication
• Financial compensation for time/travel expenses

Inclusion/Exclusion Criteria Must Be Met